Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "Mutschler 2012 Abstract Bioblast"

From Bioblast
 
Line 15: Line 15:
}}
}}
{{Labeling
{{Labeling
|injuries=Mitochondrial Disease; Degenerative Disease and Defect
|organism=Human
|organism=Human
|injuries=Mitochondrial disease
|journal=Mitochondr Physiol Network
|journal=Mitochondr Physiol Network
|articletype=Abstract
|articletype=Abstract

Latest revision as of 15:35, 23 February 2015

Mutschler R (2012) Regenerative mitochondrial medicine – from basic research to medical practice. Mitochondr Physiol Network 17.12.

Link: MiPNet17.12 Bioblast 2012 - Open Access

Mutschler R (2012)

Event: Bioblast 2012

Rainer Mutschler

Where mitochondria are damaged and energy production is reduced, there are resulting deseases and malfunctioning of tissue and organs. The most important tool in regenerative mitochondrial medicine during treatment of secondary mitochondropathia is to avoid the causing noxes. Further, very important parts in regenerative mitochondrial medicine are orthomolecular therapy, nutritional therapy and microbiological intestinal therapy as well as treating the milieu. The latest novelty is focussing on the amygdala for neurostress reduction.

  1. Mutschler R Regenerative Mitochondrien-Medizin - von der Forschung in die Praxis (2012) Zs f Orthomol Med 10: 20-22.

Keywords: Regenerative mitochondrial medicine


Labels:

Stress:Mitochondrial disease  Organism: Human 







Affiliations and author contributions

CFI Centrum für Integrative Medizin Speyer, KompetenzCentrum für Ganzheitliche Gesundheit und Gesundheitsförderung, Speyer, Germany; Email: [email protected]

Help